Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
business development
Biotech
Catalyze360 aims to expand beyond Lilly's core drug ethos
As Lilly continues to capitalize on its trove of Mounjaro cash, the company’s early external innovation arm, Catalyze360, is welcoming all comers.
Fraiser Kansteiner
Aug 19, 2024 9:43am
Bayer pharma BD chief says group overhaul not slowing deals
Aug 15, 2024 2:30pm
Biogen CEO said no risky deals in 2023. Now he’s ready to be bold
Aug 1, 2024 10:34am
J&J hooks Proteologix for at least $850M in cash
May 16, 2024 10:12am
Geopolitics threatens Chinese biotechs' hot out-licensing biz
Apr 11, 2024 4:00am
Equillium delivers new lupus data to Ono's doorstep
Apr 1, 2024 10:53am
